,i  #aafth ,,congress  #b;d ,session    
,h4 ,r4 #ehid  ,,in ,,the ,,house ,,of  
,,representatives  ,february #ac1       
#bjbj,ms4 ,davids of ,kansas 7for       
herself1 ,ms4 ,slotkin1 and ,ms4        
,finkenauer7 introduced the following   
bill2 which was referred to the         
,committee on ,energy and ,commerce  ,a 
,,bill  ,to direct the ,secretary of    
,health and ,human ,services to issue   
guidance requiring the list prices of   
drugs to be included in advertisements  
for such drugs4  #a4 ,short title ,this 
,act may be cited as the ,transparency  
in ,prescription ,drug ,advertising     
,act4  #b4 ,pricing transparency in drug
 advertising  7a7 ,in general ,not later
 than one year after the date of        
enactment of this ,act1 the ,secretary  
of ,health and ,human ,services1 in     
consultation with the ,commissioner of  
,food and ,drugs and the ,administrator 
of the ,centers for ,medicare  ,medicaid
 ,services1 shall issue department-wide 
guidance requiring the list prices of   

drugs to be included1 as appropriate1 in
 all advertising of drugs1 including by 
means of television1 newspapers1 the    
internet1 or other media4  7b7          
,enforcement2 consistency ,the guidance 
under subsection 7a7-- 7#a7 shall       
include appropriate enforcement         
mechanisms for failure to make          
disclosures in accordance with the      
guidance2 and  7#b7 should be consistent
 with the regulation of the ,centers for
 ,medicare  ,medicaid ,services related 
to drug pricing transparency4